|
TIAL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.218900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.416610E-04 |
| Normal-vs-Stage2 |
1.600620E-01 |
| Normal-vs-Stage3 |
6.501200E-01 |
| Normal-vs-Stage4 |
6.580400E-01 |
| Stage1-vs-Stage2 |
4.751800E-01 |
| Stage1-vs-Stage3 |
7.818100E-03 |
| Stage1-vs-Stage4 |
1.849700E-02 |
| Stage2-vs-Stage3 |
2.718800E-01 |
| Stage2-vs-Stage4 |
3.144200E-01 |
| Stage3-vs-Stage4 |
9.901800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.108340E-02 |
| Normal-vs-AfricanAmerican |
1.912440E-01 |
| Normal-vs-Asian |
1.233570E-02 |
| Caucasian-vs-AfricanAmerican |
8.692400E-01 |
| Caucasian-vs-Asian |
1.043510E-02 |
| AfricanAmerican-vs-Asian |
7.179300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.988000E-02 |
| Normal-vs-Female |
6.763000E-04 |
| Male-vs-Female |
6.844200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.219400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.261880E-03 |
| Normal-vs-Age(61-80Yrs) |
4.556400E-02 |
| Normal-vs-Age(81-100Yrs) |
5.598200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.522800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.056000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.239000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.547160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.672200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.513650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.37760000038656E-07 |
| Normal-vs-Grade 2 |
2.25179999999714E-05 |
| Normal-vs-Grade 3 |
2.339000E-01 |
| Normal-vs-Grade 4 |
3.987400E-01 |
| Grade 1-vs-Grade 2 |
1.216350E-01 |
| Grade 1-vs-Grade 3 |
2.380400E-03 |
| Grade 1-vs-Grade 4 |
4.019400E-04 |
| Grade 2-vs-Grade 3 |
1.517870E-03 |
| Grade 2-vs-Grade 4 |
2.368400E-04 |
| Grade 3-vs-Grade 4 |
8.412400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.00720000006937E-07 |
| Normal-vs-ccB subtype |
9.769800E-01 |
| ccA subtype-vs-ccB subtype |
8.11629999986074E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.223200E-03 |
| Normal-vs-N1 |
5.454200E-01 |
| N0-vs-N1 |
1.208220E-01 |
|
|
